Clinical Trial Update: Phase II Study of ASP3550 in Patients With Prostate Cancer [Phase 2]

View source ↗

Summary

This document notes the completion of a Phase II study of ASP3550 in patients with prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• ASP3550

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED